|
 |
TEMODARThis page contains recent news articles, when available, and an overview of TEMODAR but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: TEMODAR (when available) Temozolomide is an antineoplastic agent. It causes death of of rapidly replicating cells, especially malignant cells, leading to regression or slowed tumor growth. For the treatment of adult patients diagnosed with anaplastic astrocytoma who have relapsed following chemotherapy Mechanism Of Action: Temozolomide is not active until it is converted at physiologic pH to the active form, 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC). The cytotoxicity of MTIC is due to alkylation of DNA at the O6 and N7 positions of guanine. News Articles on Temozolomide OncoMethylome Sciences to Perform MGMT Testing in Roche Phase III Study of ... - 05 Jan 2010 This trial will compare the current standard-of-care therapy, which is concurrent chemoradiation and adjuvant temozolomide "TMZ" (Temodar Ã’ ... istockAnalyst.com (press release) OncoMethylome krijgt contract voor fase III onderzoek - 05 Jan 2010 Het fase-III onderzoek naar Avastin behelst een vergelijking met het middel Temodar van Schering-Plough. OncoMethylome wordt betaald voor het doen van ... DeAandeelhouder.nl Rite Aid blamed in Mich. man's death - Dec 22, 2009 John Sheridan of Troy died in October 2007, about a month after he began using a drug named Temodar. A lawsuit filed on behalf of Sheridan's estate says a ... The Associated Press Detroit Wrongful Death Lawsuit Filed Over Pharmacy Error - Dec 28, 2009 Temodar (temozolomide) is an antineoplastic agent by Schering-Plough Corporation approved for the treatment of brain tumors by the FDA since 1999. ... AboutLawsuits.com Seve Ballesteros Looks To Beat Brain Cancer As His Charitable Foundation Comes ... - Dec 16, 2009 Temozolomide is also known by its brand names Temodar and Temodal. Glioblastoma multiforme, one of the gliomas, is the most common and aggressive type of ... Medical News Today (press release) Wall Street Firm Believes Risks are Priced into Merck Shares (MRK) - Nov 9, 2009 ...but believes the current valuation already implies the loss of more than 50% of the cholesterol franchise, 100% of US Temodar sales, and up to 30% of ... Dividend.com (blog) Pfizer Broke the Law by Promoting Drugs for Unapproved Uses - Nov 8, 2009 Schering-Plough Corp. drug salesmen pitched off-label uses of a cancer drug called Temodar at the American Society of Clinical Oncology's annual conference ... Bloomberg Schering-Plough Corporation Q3 2009 Earnings Call Transcript - Oct 22, 2009 For example, we achieved 18% sales growth with Remicade, excluding currency, and solid growth of other key products such as Temodar and Nasonex. ... Seeking Alpha (blog) Upgrades: ANF, ADBE, MRK - Nov 9, 2009 And Leerink Swann upgraded shares of Merck (NYSE:MRK) from Market Perform to Outperform as the current shares price fully reflects the risk of the Temodar ... MarketNewsVideo.com Antigenics Q3 2009 Earnings Call Transcript - Oct 29, 2009 In addition to this trial, we in glioma we have another trial ongoing which is also a Phase II trial of Oncophage with Temodar in newly diagnosed patients ... Seeking Alpha (blog) TRACON Pharmaceuticals Announces Upcoming Presentation of Clinical Data on ... - Nov 9, 2009 ...being studied as an oral agent in combination with pemetrexed (Alimta(R)) and as an intravenous agent in combination with temozolomide (Temodar(R)). ... GlobeNewsWire (press release) Data Presented on Oncophage Cancer Vaccine in Recurrent Glioma at SNO 2009 - Oct 26, 2009 An additional Phase 2 study is underway evaluating Oncophage in combination with Temodar (temozolomide) in newly diagnosed glioma patients. ... Reuters TRACON Announces CRADA With NCI to Study TRC105 in Prostate Cancer - Oct 19, 2009 TRC102, a small molecule that reverses resistance to chemotherapeutics, began dosing in 2008 in a Phase 1 trial in combination with Temodar(R) and a Phase 1 ... Reuters Schering-Plough Reports Financial Results for 2009 Third Quarter - Oct 22, 2009 Sales of TEMODAR, a treatment for certain types of brain tumors, increased 2 percent (7 percent operational growth offset by 5 percent unfavorable foreign ... Reuters Merck & Co earnings climb as Januvia and Isentress impress - Oct 23, 2009 The brain cancer drug Temodar (temozolomide) increased 2% to $278 million, though the hepatitis C treatment PegIntron (pegylated interferon) decreased 6% to ... Pharma Times Leerink Swann LLC stuft MERCK auf outperform - Nov 10, 2009 Der Wegfall des halben Cholesteringeschäft, der gesamten US-Umsätze von Temodar und eines Drittels des Gewinns von Remicade und Simponi werde aber schon vom ... wallstreet-online Schering-Plough pleads guilty to conspiracy - Business - International... - Aug 30, 2006 It improperly promoted Temodar for use in brain tumors and metastatic cancer, ... Temodar was approved in 1999 for a specific type of brain tumor, ... New York Times Drug Temodar Ups Brain Cancer Survival - Oct 30, 2007 By Charlene Laino. Oct. 30, 2007 (Los Angeles) -- People with a type of brain cancer that was invariably fatal only five years ago now have a shot at living ... WebMD New treatments extend brain cancer survival a bit - May 22, 2008 Patients then get Temodar for six months or more, or until the tumor ceases to respond. Brawley expressed hope that Genentech Inc's drug Avastin soon may be ... Reuters India Barr challenges patent on Schering-Plough drug - Jul 24, 2007 N) brain-cancer drug Temodar in an effort to bring generic versions to the market ... A Schering-Plough spokeswoman said the main patent protecting Temodar, ... Reuters Temodar Approved for Glioblastoma Multiforme - Mar 17, 2005 The Food and Drug Administration (FDA) has granted approval of a new indication for Temodar (temozolomide). The drug, used concurrently with radiotherapy ... i-newswire.com FDA approves Temodar (temozolomide) as treatment for patients with … - Mar 16, 2005 Schering-Plough Corp reported that the US Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Steroids' side effects keep O'Connor in the hospital - Jul 20, 2006 A plan to add a second oral chemotherapy agent called Temodar was put on hold. ... The Temodar might be started after the second dose of methotrexate. ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Experts: Experimental meds option for Kennedy - Capitol Hill-... - Jun 9, 2008 Six weeks of radiation and chemotherapy with Temodar are standard, ... Temodar eventually stops working, and patients then try one experimental drug or ... msnbc.com Mayor O'Connor walking, but still in hospital - Aug 1, 2006 Doctors had hoped to start him on the chemotherapy drug Temodar, ... Temodar is expected to bolster the effects of his primary chemotherapy drug, ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Schering-Plough and Oncomethylome Sciences announce collaboration … - Nov 16, 2005 Under the collaboration, the DNA methylation status of the MGMT gene is being evaluated for its potential role in optimizing TEMODAR therapy in patients ... carolinanewswire.com Press Release: FDA Approves TEMODAR(R) (temozolomide) as … - Mar 16, 2005 FDA Approves TEMODAR(R) (temozolomide) as Treatment for Patients With Newly Diagnosed Glioblastoma Multiforme; Schering-Plough Receives Full Approval for ... Pay-Per-View - PR Newswire - HighBeam Research … 2 Clinical Trial Combining Panzem(R) NCD and Temodar(R) in Brain … - May 29, 2007 Temodar(R) is a registered trademark of its owner and not of EntreMed, Inc. Panzem(R) is a registered trademark of EntreMed, Inc. ... RedOrbit TEMODAL(R) Approved By Japan's Ministry of Health, Labor and Welfare ... - Jul 31, 2006 TEMODAL, marketed as TEMODAR(R) in the US, is approved in 77 countries. ... Patients treated with TEMODAR Capsules may experience myelosuppression. ... RedOrbit Temodar Pill Helping Brain Tumor Patients - Apr 8, 2008 For decades, doctors have tried treating brain tumors with various kinds of chemotherapy and radiation therapy. It never worked very well because the brain ... ThePittsburghChannel.com … Multiforme; FDA approves TEMODAR (temozolomide) for patients with ... - Apr 16, 2005 2005 APR 16 - (NewsRx.com) -- Schering-Plough Corp. (SGP) reported that the US Food and Drug Administration (FDA) has granted approval for TEMODAR ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Mayor O'Connor still in hospital - Aug 4, 2006 The mayor's medical team reported that he has tolerated his first treatment this week with a second chemotherapy drug, Temodar, and will continue physical ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Schering-Plough to sue Barr on generic Temodar.(Brief article) - Jul 30, 2007 US generics group Barr Pharmaceuticals says that its subsidiary, Barr Laboratories, has initiated a challenge of the patent listed for Schering-Plough's ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Schering-Plough Submits New Drug Application In Japan for TEMODAL( … - Nov 1, 2005 Patients treated with TEMODAR Capsules may experience myelosuppression. ... TEMODAR Capsules are contraindicated in patients who have a history of ... Free with registration - PR Newswire - AccessMyLibrary.com FDA CAPSULES - Mar 29, 2005 TEMODAR APPROVED FOR TREATING COMMON BRAIN CANCER. The FDA has approved the drug Temodar (temozolomide) for a new use as a treatment for glioblastoma ... Pay-Per-View - Newsday - ProQuest Archiver Gene Markers Predict Drug Response in Brain Cancer - Feb 19, 2008 19 -- Gliomatosis cerebri patients who responded well to temozolomide (Temodar) and radiation were marked by two genetic abnormalities that frequently occur ... MedPage Today … : Barr Confirms Patent Challenge of TEMODAR(R). - PR Newswire | … - Jul 24, 2007 Barr Confirms Patent Challenge of TEMODAR(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research NCCN: Oncologists Add Temodar to CNS Treatment Algorithm - Mar 18, 2005 By Ed Susman,. HOLLYWOOD, Fla.-The National Comprehensive Cancer Network (NCCN) has put its stamp of approval on Temodar (temozolomide) as a front-line ... MedPage Today TRACON Pharmaceuticals Doses the First Patient in a Phase 1 Clinical ... - Jun 18, 2008 Intravenous TRC102 is also being dosed to cancer patients in a Phase 1 clinical trial in combination with Temodar(r) being conducted at University Hospitals ... Lifescience-online EntreMed's Panzem(R) Demonstrates Antitumor Activity In Brain Tumor … - Dec 22, 2006 Temodar(R) is a registered trademark of its owner and is not a registered trademark of EntreMed, Inc. EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage ... Medical News Today - Medical News Today (press release) FDA Details Drug Risks - Sep 19, 2007 Schering-Plough spokeswoman Katherine Cantone said Temodar"s label notes aplastic anemia as a potentially rare occurrence in the extremely ill brain cancer ... Cancerpage.com … Multiforme; FDA approves TEMODAR (temozolomide) for patients with ... - Apr 12, 2005 2005 APR 12 - (NewsRx.com) -- Schering-Plough Corp. (SGP) reported that the US Food and Drug Administration (FDA) has granted approval for TEMODAR ... Pay-Per-View - Science Letter - Factiva, from Dow Jones CHMP Recommends Approval In The European Union (EU) For New … - Dec 9, 2008 TEMODAR capsules (temozolomide) received accelerated approval from the US Food ... TEMODAR Capsules are contraindicated in patients who have a history of ... Medical News Today - Medical News Today (press release) … Clinical Trial of Genasense(R) Plus Abraxane(R) and Temodar(R) As... - Nov 29, 2006 ...was combined with Abraxane(R) (paclitaxel protein-bound particles; Abraxis Oncology, Inc.) and Temodar(R) (temozolomide; Schering Plough, Inc.). ... RedOrbit … Multiforme; FDA approves TEMODAR (temozolomide) for patients with ... - Apr 15, 2005 2005 APR 15 - (NewsRx.com) -- Schering-Plough Corp. (SGP) reported that the US Food and Drug Administration (FDA) has granted approval for TEMODAR ... Pay-Per-View - Drug Week - Factiva, from Dow Jones SP's Temodar boosts survival in GBM by 4 yrs. - Nov 5, 2007 Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme, who are treated with Schering-Plough's chemotherapy ... $4.95 - Pharma Marketletter - ECNext EntreMed presents preclinical results for combination therapy with... - Mar 1, 2006 Treatment with either 2ME2 or Temodar alone was only marginally effective in slowing tumor growth. In a separate preclinical study, 2ME2 was used in ... Free with registration - BIOTECH Patent News - AccessMyLibrary.com NeoPharm: Brain Tumor Agent May Struggle to Overtake Temodar - May 26, 2005 The PRECISE trial aims to examine overall survival, safety and quality of life in patients receiving IL13-PE38QQR compared to patients receiving Gliadel ... RedOrbit … 2 Clinical Trial Combining Panzem(R) NCD and Temodar(R) in Brain … - May 29, 2007 Carolyn ... glioblastoma studies combining Panzem(R) NCD with Temodar(R) ... Positive results from the Panzem(R) NCD/Temodar(R) clinical study currently . ... Pay-Per-View - PR Newswire - HighBeam Research … Temodar, Baxter's Feiba etc OKed in Japan.(Schering-Plough's Temoda... - May 15, 2006 The Second Sub-Committe on Drugs of Japan's Council on Drugs and Food Sanitation (CDFS) has recommended the following approvals: US drugmaker ... $4.95 - Pharma Marketletter - ECNext TEMODAL(R) Approved in European Union For Treatment of Newly … - Jun 10, 2005 Patients treated with TEMODAR Capsules may experience myelosuppression. ... TEMODAR Capsules are contraindicated in patients who have a history of ... $4.95 - PR Newswire - ECNext Patients With Newly Diagnosed Glioblastoma Multiforme - Health Canada... - Feb 6, 2006 Schering-Plough markets temozolomide in the United States as TEMODAR(R) Capsules ... Patients treated with TEMODAR Capsules may experience myelosuppression. ... Medical News Today - Medical News Today (press release) Temodar (temozolomide) Capsules - Mar 15, 2005 New Indication: Temodar (temozolomide) capsules is approved for the treatment of patients with newly diagnosed high-grade gliomas concomitantly with ... Medscape Genta's Genasense shows preclinical efficacy - Nov 10, 2006 The use of Genasense plus Abraxis' Abraxane (paclitaxel protein-bound particles) and Schering-Plough's Temodar (temozolomide) also proved synergistic in a ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Surgeon's trial study on cancer is hailed / Brain tumor took his... - May 28, 2008 Under the trial protocol, some patients received Temodar for the first five days of the month, ... The response was better with the highest dose of Temodar. ... Houston Chronicle FDA Safety Labeling Changes: Maxaquin, Temodar, Trileptal - Jun 15, 2005 June 15, 2005 — The US Food and Drug Administration (FDA) approved in March revisions to safety labeling to advise that use of lomefloxacin HCl tablets is ... Medscape Temodal(R) Approved By Japan's Ministry Of Health, Labor And Welfare ... - Aug 7, 2006 TEMODAL, marketed as TEMODAR(R) in the US, is approved in 77 countries. ... Patients treated with TEMODAR Capsules may experience myelosuppression. ... Medical News Today - Medical News Today (press release) Bratton v. Schering-Plough Corp., No. CV 07-0653-PHX-JAT (D.Ariz. 07/... - Jul 12, 2007 Intron/Temodar Consumer Class Action ("In re Schering-Plough"), established a procedure to consolidate before Judge Chesler newly-filed or transferred ... $2.95 - U.S. District Court, District of Arizona - VersusLaw HOW 'LIBERAL' CARE WOULD KILL TED - Jun 5, 2008 Temodar has been widely used in this country since the FDA approved it in 2000. ... Even today, only a handful of Brits with brain tumors can get Temodar. ... New York Post New indication for Temodar.(Temozolomide drug approval)(Brief Article) - Apr 4, 2005 Temozolomide (Temodar, Schering-Plough) has been approved for use concurrently with radiotherapy and as maintenance therapy after radiotherapy in adults ... Free with registration - Drug Topics - AccessMyLibrary.com Schering-Plough to Pay $435M in Improper Drug Marketing Case - Sep 4, 2006 Also, the feds say that Schering-Plough improperly promoted Temodar (a cancer drug) and Intron A (which treats hepatitis C, among other illnesses). ... Pay-Per-View - Report on Medicare Compliance - Factiva, from Dow Jones Schering-Pluogh's Temodar gets additional indication for GBM. - Apr 18, 2005 Schering-Pluogh's Temodar gets additional indication for GBM. WASHINGTON -- The Food and Drug Administration has approved Schering-Plough Corp. ... $9.94 - Chain Drug Review - Alacra Store FDA clears Schering-Plough's Temodar.(Product development)(Brief … - Mar 28, 2005 US drugmaker Schering-Plough's Temodar (temozolomide) has been approved by the US Food and Drug Administration for use in combination with radiotherapy for ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Article: Schering-Pluogh's Temodar gets additional indication for... - Apr 18, 2005 Schering-Pluogh's Temodar gets additional indication for GBM.(drug approval)(glioblastoma multiforme) ... find Chain Drug Review articles. Pay-Per-View - Chain Drug Review - HighBeam Research Health Canada Approves Temodal (Temozolomide) for Patients With … - Feb 2, 2006 Patients treated with Temodar Capsules may experience myelosuppression. ... Temodar Capsules are contraindicated in patients who have a history of ... DG News A grim diagnosis: Kennedy's brain cancer is worst kind - May 20, 2008 Also, the fairly recent addition of Temodar has brought a slight increase in the number of patients who beat average survival odds, she added. ... FOXNews EU's CHMP Recommends Approval of TEMODAL(R) (Temozolomide) for … - Apr 25, 2005 Schering-Plough received full approval of temozolomide ( TEMODAR( R ) ) from the ... Patients treated with TEMODAR Capsules may experience myelosuppression. ... i-newswire.com Press Release: Long-Term Data from a Landmark Phase III Trial Show … - Oct 30, 2007 Patients with Newly Diagnosed GBM Patients treated with TEMODAR Capsules may ... Forty-nine percent of patients treated with TEMODAR reported one or more ... Pay-Per-View - PR Newswire - HighBeam Research Expertos confirman que vacuna para tumores cerebrales aumenta el … - Jun 3, 2008 En el ensayo finalizado recientemente, la vacuna fue empleada en combinación con Temodar, un fármaco contra el cáncer de cerebro comercializado por ... La Tercera ALICIA'S STORY Goodbye, interferon, hello, chemo -- new step in the … - Feb 2, 2007 That made Temodar seem like a better choice; steadier, more constant. Silently I kept saying, "I'm ready, I'm ready" -- even while Dr. Jahan spoke about the ... San Francisco Chronicle Ted Kennedy's Expanded Cancer Arsenal - Jun 3, 2008 The first new chemo agent for brain tumors in 20 years, Temodar ... With further proof of benefit, Temodar earned its way up to frontline therapy about ... U.S. News & World Report Winst Schering-Plough meer dan verdubbeld - Jul 23, 2007 De omzetgroei is met name te danken aan de groei van voorgeschreven medicijnen als Remicade (+28%), Nasonex (+22%) en Temodar (+26%). ... Trouw Schering-Plough presteert beter dan verwacht - Apr 19, 2007 De omzetgroei is met name te danken aan de groei van voorgeschreven medicijnen als Remicade (+34%), Nasonex (+24%) en Temodar (+20%). ... Trouw Promising chemo, therapeutic viruses, cutting-edge surgery debut at... - May 10, 2006 The chemotherapy drug Temodar (temozolomide), first tested by MD Anderson ... Researchers know that resistance to Temodar occurs in many patients. ... News-Medical.net ×©×¨×™× ×’-פל×?ו תשל×? 435 מיליון דולר בשל ×”×•× ×?×” - Aug 30, 2006 ...מדובר בחקירה ×?זרחית ×‘× ×•×’×¢ לשיווק של שתי תרופות, Intron A, תרופה לטיפול בסרטן ו- Temodar, ... ynet ידיעות ×?×—×¨×•× ×•×ª - ynet ידיעות ×?×—×¨×•× ×•×ª MD Anderson: Setting the Benchmark in Brain Tumor Treatment - May 14, 2006 The chemotherapy drug Temodar (temozolomide), first tested by MD Anderson ... Researchers know that resistance to Temodar occurs in many patients. ... Medical News Today - Medical News Today (press release) Setting the Benchmark in Brain Tumor Treatment - May 9, 2006 The chemotherapy drug Temodar (temozolomide), first tested by MD Anderson ... Researchers know that resistance to Temodar occurs in many patients. ... newswise.com Setting the benchmark in brain tumor treatment - Nov 5, 2006 The chemotherapy drug Temodar (temozolomide), first tested by MD Anderson ... Researchers know that resistance to Temodar occurs in many patients. ... innovations report Setting The Benchmark In Brain Tumor Treatment At The University Of … - May 16, 2006 The chemotherapy drug Temodar (temozolomide), first tested by MD Anderson ... Researchers know that resistance to Temodar occurs in many patients. ... Medical News Today - Medical News Today (press release) Press Release: Phase 2 Results for EntreMed's Panzem(R) NCD Brain … - Jun 5, 2007 Positive results from the Panzem(R) NCD/Temodar(R) clinical study currently underway at Duke would allow us to evaluate this combination in a larger ... Pay-Per-View - PR Newswire - HighBeam Research Open-Label Bites Drug Duo - Dec 19, 2008 Considering that Temodar is on its way to becoming a blockbuster, ... If CDX-110 can improve the survival results of Temodar by just a little bit, ... fool.com New weapons target deadly brain cancer Drugs, chemotherapy buy time … - Jan 2, 2005 ...*The chemotherapy drug Temodar appears promising as a tool to buy GBM ... Doctors now can figure out which patients stand to gain from Temodar using a test ... Pay-Per-View - Chicago Sun-Times - HighBeam Research New weapons target deadly brain cancer // Drugs, chemotherapy buy … - Jan 2, 2005 ...*The chemotherapy drug Temodar appears promising as a tool to buy GBM ... Doctors now can figure out which patients stand to gain from Temodar using a test ... $2.95 - Chicago Sun-Times - NewsBank EntreMed Reports Results From Phase 2 Study of Panzem. - Jun 5, 2007 Also, results from in vivo preclinical glioblastoma studies combining Panzem NCD with Temodar demonstrated tumor regression compared with either agent alone ... Free with registration - M2 Presswire - AccessMyLibrary.com ë©´ì— ì‹œìŠ¤í…œ ìž?극해 종양 세í?¬ 공격해 - Jun 3, 2008 ...ì‰?ë§? 푸ë?¼ìš°ì?˜ 테모달(Temodar)ì?€ ì?´ ë°±ì‹ ê³¼ 테모졸로마ì?´ë“œ(temozolomide)와ì?˜ ë³µí•©ì œ. ë©´ì— ì‹œìŠ¤í…œì?„ ìž?극해 암세í?¬ì—? 대í•í•˜ëŠ” 약ì?´ë‹¤. ... ë?°ì?¼ë¦¬íŒœ Temodar nel trattamento del glioblastoma multiforme - Oct 19, 2005 Il glioblastoma multiforme è la più comune forma di tumore cerebrale maligno, ed ha generalmente esito fatale. Negli Usa l'incidenza annua di glioblastoma ... XagenaSalute Press Release: Schering-Plough and ONCOMETHYLOME Sciences ( … - Nov 16, 2005 Technology to Be Used to Study MGMT Methylation Status in Glioblastoma Multiforme Brain Cancer Patients Treated with TEMODAR(R) (Temozolomide) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: EntreMed Reports Results From Phase 2 Study of … - Jun 5, 2007 Also, results from in vivo preclinical glioblastoma studies combining Panzem NCD with Temodar demonstrated tumor regression compared with either agent alone ... Pay-Per-View - M2 Presswire - HighBeam Research DIGEST - Mar 17, 2005 Temodar, taken as a capsule, was previously approved for treatment of adult patients with another form of brain tumor, anaplastic astrocytoma, ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Schering-Plough conform verwachting - DePers.nl - Jan 29, 2007 De omzetgroei is met name te danken aan de groei van voorgeschreven medicijnen als Remicade (+32%), Nasonex (+28%) en Temodar (+20%). ... DePers.nl Schering-Plough Agrees To Plead Guilty, Pay Fine | Article from The … - Aug 30, 2006 One such drug was Temodar, which the Food & Drug Administration in 1999 approved to ... Temodar, Schering's No. 4 drug, had sales of $588 million last year. ... Pay-Per-View - Washington Post - HighBeam Research O'Connor doctors take experimental tack - Jul 12, 2006 Marks said he chose Temodar because it has proven effective in treating recurrent ... "Temodar works in people when methotrexate stops working," Marks said. ... pittsburghlive.com Kennedy faces a formidable foe - May 21, 2008 Chemotherapy usually involves the drug Temodar, which is given orally and which has few ... Temodar is one of the few anti-cancer drugs able to cross the ... Seattle Times Press Release: Health Canada Approves TEMODAL(R)(temozolomide) … - Feb 2, 2006 Schering-Plough markets temozolomide in the United States as TEMODAR(R) Capsules. ... Concurrent with the approval for newly diagnosed GBM, TEMODAR also ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Schering-Plough Submits New Drug Application In Japan ... - Nov 1, 2005 Important Information Regarding U.S. Labeling for TEMODAR with Newly Diagnosed GBM ... Concurrent with the approval for newly diagnosed GBM, TEMODAR also ... Pay-Per-View - PR Newswire - HighBeam Research Article: Kennedy's prognosis looking bleak - Deseret News (Salt Lake... - May 21, 2008 Also, the fairly recent addition of Temodar has brought a slight increase in the number of patients who beat average survival odds, she added. ... Pay-Per-View - Deseret News - HighBeam Research NJ BRIEFS | Article from The Record (Bergen County, NJ) | HighBeam … - Mar 17, 2005 ...s drug Temodar won U.S. regulatory approval as a treatment for the most common and ... Temodar capsules can be used with radiation to treat glioblastoma ... Pay-Per-View - The Record - HighBeam Research Statistics tell a pretty grim tale | Article from The Record (Bergen... - May 21, 2008 Also, the fairly recent addition of Temodar has brought a slight increase in the number of patients who beat average survival odds, she added. ... Pay-Per-View - The Record - HighBeam Research Article: Agency approves drug for brain cancer - AP Worldstream | … - Mar 16, 2005 The agency said the drug, sold by Schering-Plough Corp. under the name Temodar, extended the life of patients who used the medication and had radiation ... Pay-Per-View - AP Worldstream - HighBeam Research New drug extends lives of brain cancer patients.(Updates) - Jul 1, 2005 The FDA has granted approval of a new indication for Temodar ... Temodar now can extend the lives of adult patients newly diagnosed with the most common ... $4.95 - FDA Consumer - ECNext Schering-Plough reports lower profit - MarketWatch - Oct 21, 2008 Also rising were sales of its brain-cancer therapy Temodar and allergy ... Temodar sales leapt 27% to $273 million, while Nasonex rose 6% to $258 million. ... MarketWatch Pfizer Goes Bargain Hunting - Apr 16, 2008 A 90-patient trial will test the combo of CDX-110 and the chemotherapy Temodar, from Schering-Plough (nyse: SGP - news - people ), against Temodar alone. ... Forbes Schering-Plough Posts Major Increase in Net Income - Oct 20, 2006 Sales of Temodar grew 18% to $179 million due to increased utilization outside the US ... Schering-Plough does predict that the growth rates for Temodar may ... Genetic Engineering News - Genetic Engineering News (press release) Massive cancer gene search finds potential new targets in brain tumors - Sep 4, 2008 Brain tumors that contain a methylated, or silenced, form of a gene known as MGMT are known to be more susceptible to cancer drug temozolomide (Temodar). ... eurekalert.org Analysis: Schering-Plough posts strong Q2 - Jul 23, 2007 Global sales of the allergy treatment Nasonex rose 22 percent to $295 million, while sales of the brain tumor medication Temodar jumped 26 percent to $216 ... United Press International Q2 2007 EntreMed, Inc. Earnings Conference Call - Final. - Aug 15, 2007 These data encouraged Entremed and the clinical team at Duke to pursue a clinical trial for Panzem NCD in combination with temozolomide trademarked Temodar ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Oncolin Therapeutics Announces Its Lead Technology Has Shown to Be … - Apr 14, 2008 The early testing has yielded results in animals that are equivalent to that of Temodar(R), which is one of the leading cancer treatments for brain cancer ... Genetic Engineering News - Genetic Engineering News (press release) Marijuana as a Treatment for PTSD - May 26, 2008 It ballyhooed Temodar, a drug from Schering-Plough shown in clinical trials to extend ... Temodar “is on track to surpass $1 billion in sales this year, ... counterpunch.org Avastin and Irinotecan prolongs survival in recurrent Glioblastoma M ... - Oct 24, 2007 Role of Avastin would be in combination with the only approved agent ( Temodar) for frontline treatment and will be used in recurrent cases ... Gerson Lehrman Group BioWorld Financial Watch Editor - Dec 31, 2007 The drug, however, performed comparably to Temodar. What's more, ARRY-886, targeting a key point in the Ras/Raf/MEK/ERK signaling pathway, is oral (like ... BioWorld Online - BioWorld Online Bevacizumab Plus Irinotecan Extends Survival - Oct 25, 2007 Radiation and Temodar followed by Temodar remains the standard of care." In a related paper, which appears in the same issue, researchers examined the ... Medscape Oncolin Therapeutics Announces Its Lead Technology Has Shown To Be … - Apr 16, 2008 The early testing has yielded results in animals that are equivalent to that of Temodar®, which is one of the leading cancer treatments for brain cancer ... Medical News Today - Medical News Today (press release) Atlanta health, diet and fitness news | ajc.com - Feb 16, 2006 A research study is underway to determine if stereotactic radiosurgery combined with Temodar improves the overall survival time of patients with brain ... Atlanta Journal Constitution PERSONAL EXPERIENCE / AS A NEUROSURGEON, Samuel … - Jan 30, 2006 Every month, he takes a large dose of Temodar for five days. Then, when his white blood cell counts hit rock bottom - about 21 days - he gets the vaccine, ... Houston Chronicle Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of … - Sep 17, 2007 We are hoping that we can deplete the level of AGT with Temodar(R) and that the combination of agents will improve anti-tumor responses and outcomes. ... $4.95 - PR Newswire - ECNext Schering Sales sentenced to pay $435M in drug pricing, marketing case - Jan 17, 2007 One example was Temodar, a drug the FDA had approved to treat a type of brain ... Prosecutors said Schering promoted Temodar to treat several other types of ... $2.95 - Associated Press Archive - NewsBank Brand Names/Synonyms: TEMODAR is also known by the following brand names and/or synonymsAIDS-129717; AIDS129717; CHEMBANK1819; Methazolastone; NSC362856; Temodal; Temodar; Temozolamide; Temozolodida [Spanish]; Temozolomide; Temozolomide [Ban:Inn]; Temozolomidum [Latin] Drug Category: TEMODAR is categorized under the following by the FDA: Antineoplastic Agents; ATC:L01AX03 Dosage Forms: CAPSULE Absorption: Rapid and complete absorption in the gastrointestinal tract Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |